SEK 33,9 million from Cancerfonden to researchers at Labmed

In Cancerfonden’s latest call, SEK 33,9 million was awarded to 12 researchers at the Department of Laboratory Medicine for the years 2027-2029.

Mikael Björnstedt , Professor

Title: “Integrated Precision Stratification and Selenium-mediated Targeted Redox Therapy in Resistant Tumors with Special Emphasis on HPB cancers”

Project grant, total amount: SEK 3 750 000

Jonas Fuxe , Professor

Title: “Cancer cell plasticity as a driver of immune evasion and lymphatic metastasis”

Project grant, total amount: SEK 3 750 000

Yizhou Hu , Researcher

Title: “Defining and targeting the stromal lipid niche in high-risk neuroblastoma through spatial MultiOmics”

Project grant, total amount: SEK 3 000 000

Andri Lemarquis , Assistant Professor

Title: “The role of recent thymic emigrants in tumor control”

Project grant, total amount: SEK 3 000 000

Magdalini Lourda , Docent

Title: “LUMEN: Liquid biopsy and organoid modelling to understand and predict neurodegeneration in Langerhans cell histiocytosis”

Project grant, total amount: SEK 3 000 000

Helen Kaipe , Docent

Title: “Combining tumorreactive T cells and CAF targeting to improve immunotherapy in pancreatic cancer”

Project grant, total amount: SEK 3 000 000

Anders Mutvei , Docent

Title: “Lysosome abundance and organization in cancer”

Project grant, total amount: SEK 3 000 000

Dhifaf Sarhan , Docent

Title: “Programming adaptive NK cell memory for treatment durability and relapse prevention in high-grade serous ovarian cancer”

Project grant, total amount: SEK 3 000 000

Matti Sällberg , Professor

Title: “Genetic vaccines and immune-based therapies to prevent severe liver disease and cancer caused by chronic viral hepatitis: Therapy development and models”

Project grant, total amount: SEK 3 000 000

Oscar Wiklander , Assistant Professor

Title: “Extracellular Vesicles as an Integrated Platform for Precision-Guided Cancer Therapy”

Project grant, total amount: SEK 3 000 000

Peter Bergman , Professor

Title: “Can a new drug reduce intestinal damage during chemotherapy treatment by activating the natural immunity in the intestinal mucosa?”

Project grant, total amount: SEK 1 600 000

Stephan Mielke , Professor

Title: “Early risk stratification in CAR T-cell therapy to improve safety, access and outcome”

Project grant, total amount: SEK 800 000

/Public Release. View in full here.